ClinicalTrials.gov
public full text
Public Domain
Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease
This study aimed to determine the efficacy and safety of lucerastat oral monotherapy in adult subjects with Fabry disease.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Quitotriosidade em pacientes com Doença de Fabry : um possível marcador bioquímico auxiliar na terapia da reposição enzimática#1220057
- A Study of Patients With Fabry Disease (US Specific)#859989
- Treatment Protocol of Replagal for Patients With Fabry Disease#909348
- Post Trial Access to Lucerastat for Patients With Fabry Disease Who Participated in Study ID-069A302#1322691
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of Lucerastat (CDP923) After Multiple Dosing in Healthy Subjects#854437
Record · ID 1211623
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive